UNH Stock Analysis & Forecast (2026)

UnitedHealth Group Incorporated Healthcare Healthcare Plans
$390.44
Current Price
64%
Hold
View Plans
Data refreshed: August 31, 2026

Key Financial Metrics

Market Cap
$350.46B
P/E Ratio (TTM)
25.1x
P/E Forward
17.4x
Revenue Growth
0.4%
Gross Margin
19.7%
Net Margin
3.1%
Return on Equity
14.2%
Debt/Equity
0.69

AI Analysis Summary

UnitedHealth Group Incorporated (UNH) is a Healthcare company in the Healthcare Plans industry with a 64% Hold Score. Key strengths include Return on Equity (14.2%). The score on this page is a five-factor screen — revenue growth, gross margin, net margin, return on equity and debt-to-equity — each scored against fixed thresholds from a neutral starting point of 50%. The eight-section analysis, including moat, free cash flow, dilution and valuation, runs in the full report.

Revenue Growth: Moderate Gross Margin: Average Net Margin: Thin Return on Equity: Good Debt/Equity: Elevated

This analysis is generated by StrongBuyAnalytics AI using publicly available financial data from SEC filings, earnings reports, and market feeds. It is not personalized investment advice. See our methodology and disclaimer.

Why UNH Has a 64% Score

3 of the inputs in our model moved UNH's score away from the neutral baseline of 50%, landing it at 64% (Hold). Each one below is a specific figure from UnitedHealth Group Incorporated's reported financials, not a judgement call:

Recent Catalysts for UNH

5 data points sit outside the score itself but bear on UnitedHealth Group Incorporated's next few quarters. They are reported here as observations, not predictions:

Earnings grew 61.5% — accelerating profitability could drive re-rating.
Wall Street consensus target is $475.23 (+21.7% from current price), based on 26 analyst estimates.
Analyst consensus recommendation: Buy.
Institutional ownership at 89.7% — strong smart-money backing.
Dividend yield of 2.36% provides income while you wait for capital appreciation.

UNH vs. ABBV, MRK, AMGN, JNJ

UNH is the only Healthcare Plans company we cover, so the comparison uses the nearest Healthcare companies by market capitalisation instead.

Ticker Price Market Cap P/E Rev Growth Net Margin ROE
UNH $390.44 $350.46B 25.1x 0.4% 3.1% 14.2%
ABBV $256.24 $452.81B 72.2x 10.2% 9.8%
MRK $147.96 $365.04B 118.4x 5.1% 4.8% 7.0%
AMGN $431.12 $233.08B 26.8x 9.5% 23.0% 91.5%
JNJ $266.33 $641.83B 30.9x 6.6% 21.5% 25.7%

Main Risks for UNH Investors

1 measurable risk showed up in UnitedHealth Group Incorporated's numbers. This is not a complete list of what could go wrong — only what is visible in the data we score:

Low beta of 0.63 suggests limited upside participation in bull markets.

UNH Balance Sheet & Cash Flow

UnitedHealth Group Incorporated's liquidity and cash generation as of the most recent filing — note the cash position of $31.47B against $73.33B of debt:

Total Cash
$31.47B
Total Debt
$73.33B
Current Ratio
0.78
FCF Yield
6.9%
EBITDA
$26.68B
Operating Margin
7.1%

Figures are drawn from UnitedHealth Group Incorporated's most recent balance sheet and cash flow statement as filed with the SEC. See the filings themselves.

UNH Valuation Snapshot

Trailing P/E
25.1x
Growth premium
Forward P/E
17.4x
Earnings growth expected
Price / Book
3.6x
Premium
PEG Ratio
1.22
Fairly valued
Analyst Target (Mean)
$475.23
Range: $313 – $529
Dividend Yield
2.36%
5Y avg: 1.65%
52-Week Price Range — UNH is trading at 65% of its range
$255.97 (52W Low) $461.62 (52W High)

Who Holds UNH? — Institutional 13F Filings

Institutional investment managers with >$100 M in qualifying assets must disclose their equity positions quarterly on SEC Form 13F — typically within 45 days of quarter-end. Search those filings below to see which hedge funds, mutual funds, and asset managers reported UNH as a holding, how many shares they held, and how positions changed quarter over quarter.

Search 13F Filings for UNH Free · no sign-in required · live SEC EDGAR data
What you see free
Which institutions reported UNH, share counts, reported values, and direct links to the SEC filing.
Research Pro adds
Full manager portfolios — every position a fund holds, quarter-over-quarter changes, and concentration weights.
Data limitation
13F shows long equity positions as of the filing date. Short positions, full derivatives, and current intent are not disclosed.

Is UNH a Buy Right Now?

We do not answer that question for you, and we do not publish buy or sell calls. What we publish is a score: UNH rates 64% on our five-factor fundamentals screen, which puts it in the "Hold" band. Everything below explains how it got there so you can disagree with it.

64% · Hold band

UnitedHealth Group Incorporated clears some of our thresholds and misses others. On the positive side, return on equity (14.2%). A middling score means the fundamentals are genuinely ambiguous, not that we have hedged.

UNH Earnings & Revenue Outlook

UnitedHealth Group Incorporated reported revenue growth of 0.4% year over year, against a Healthcare Plans peer set where scale and pricing power vary widely. Growth that slow contributes little to the score on its own; margins and capital efficiency carry more weight for UNH.

Earnings grew 61.5% over the same period, outpacing revenue — a sign of operating leverage.

Track upcoming report dates on our earnings calendar.

UNH Stock Forecast (Next 3–12 Months)

This is a fundamentals outlook, not a price target — we do not publish one. It describes what UnitedHealth Group Incorporated's current financials imply about the next three to twelve months if the trends in them hold.

Mixed: Revenue growth of 0.4% sits alongside metrics that neither help nor hurt the score materially. On the fundamentals alone there is no strong case in either direction for UNH at present.

Bull Case for UNH

These are the UnitedHealth Group Incorporated figures that push the score up, taken straight from the most recent reported financials:

  • Return on Equity (14.2%)

Learn More About Stock Analysis

Free 14-Min Course
Instructor
StrongBuy Analytics
Fundamental Research Team
How to Read Your Research Report
★★★★★ 4.9 rating
14Min
15Chapters
FreeNo sign-up

See how every metric on this UNH page — quality score, valuation, DCF scenarios, confidence, and data limitations — fits into a professional research report.

Generate My Free UNH Report

Guides to the specific measures used in this UNH analysis:

Fundamental Analysis Guide

How the financial statements behind this page fit together.

Understanding P/E Ratio

What UNH's 25.1x multiple does and does not tell you.

Return on Equity (ROE)

Why UNH's 14.2% return on equity matters for stock selection.

Stock Valuation Methods

How DCF, multiples and asset-based approaches value a company like UnitedHealth Group Incorporated.

How to Read Earnings Reports

Where the UNH growth and margin figures on this page come from.

What Are Demand Zones?

The technical side we deliberately keep out of the UNH score.

Related Tools for UNH

Demand Zone Analyzer UNH Live Chart UNH SEC Filing News Earnings Calendar Institutional Ownership Sector Scanner Average Down Calculator

UNH SEC Filing News

Latest SEC filings for UNH explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.

Loading recent SEC filings…
View all UNH SEC Filing News →

Frequently Asked Questions about UNH

Is UNH a good buy right now?
We do not issue buy or sell calls. UNH has a Strong Buy Score of 64% (Hold), which is a fundamentals rating, not a recommendation. That is a middling result: UNH has real strengths alongside metrics that drag the score down. The score is helped most by return on equity (14.2%). Read how scores work to see what each input contributes.
What is the UNH stock forecast for 2026?
We publish a fundamentals outlook rather than a price target. For 2026 the UNH view rests on revenue growth of 0.4%, a net margin of 3.1% and a trailing P/E of 25.1x, which together produce the 64% Strong Buy Score. Our methodology explains how those inputs are weighted.
What are key support and resistance levels for UNH?
Support and resistance are technical levels, so they are not part of the fundamentals score. You can see current UNH demand zones (support) and supply zones (resistance) on our demand zones page. With UNH at $390.44, the tool shows how far the stock sits from the nearest zone.
Which companies are UNH's closest peers?
On this page UNH is compared with ABBV, MRK, AMGN, JNJ. UNH is the only Healthcare Plans company we cover, so the comparison uses the nearest Healthcare companies by market capitalisation instead. The table puts UNH's a gross margin of 19.7%, an ROE of 14.2%, a debt-to-equity ratio of 0.69 next to the same figures for each peer.
What is UnitedHealth Group Incorporated's market cap and P/E ratio?
As of August 31, 2026, UnitedHealth Group Incorporated (UNH) has a market cap of $350.46B, a trailing P/E of 25.1x and a forward P/E of 17.4x. Valuation is one of the inputs to the Strong Buy Score, alongside growth, margins, capital efficiency and balance-sheet strength.
Where does the UNH data on this page come from?
Company financials come from UnitedHealth Group Incorporated's own filings with the SEC, with prices and consensus estimates from market data feeds; the figures on this page were last refreshed on August 31, 2026. Our data sources page lists every provider and how often each one is updated.
Is the UNH analysis PDF report free?
Your first UNH report is free and does not require a card. The score on this page is a five-factor screen; the report runs the deeper eight-section analysis, adding moat, free cash flow, share dilution and valuation work that is not on this page. Further reports are covered by a subscription; see pricing for the current plans.

This UNH analysis is for educational and informational purposes only and does not constitute financial advice. All data is sourced from public filings and market feeds. Past performance does not guarantee future results. Read our full disclaimer.